Imaging changes after stereotactic body radiation therapy for lung and liver tumors

Expert Review of Anticancer Therapy

Volumn 11, Issue 4, 2011, Pages 613-620

  Lo, Simon S ^a   Teh, Bin S ^b   Wang, Jian Z ^c   Huang, Zhibin ^d   Zook, Jennifer ^e   Price, Tracy ^e   Mayr, Nina A ^c   Grecula, John C ^c   Timmerman, Robert D ^f   Cardenes, Higinia R ^e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

imaging changes; liver; lung; radiation; stereotactic

Indexed keywords

FLUORODEOXYGLUCOSE;

CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGE DISPLAY; LIVER DISEASE; LIVER TUMOR; LUNG INJURY; LUNG TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE DISTRIBUTION; RADIATION FIBROSIS; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION SICKNESS; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME;

DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; RADIOSURGERY;

EID: 79955117156     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.164     Document Type: Review

References (31)

1. Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: a novel treatment modality. Nat. Rev. Clin. Oncol. 7(1), 44-54 (2010).
2. Lo SS, Fakiris AJ, Papiez L et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Expert Rev. Anticancer Ther. 8(1), 87-98 (2008).
3. Lo SS, Fakiris AJ, Teh BS et al. Stereotactic body radiation therapy for oligometastases. Expert Rev. Anticancer Ther. 9(5), 621-635 (2009).
4. Lo SS, Cardenes HR, Teh BS et al. Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev. Anticancer Ther. 8(12), 1939-1951 (2008).
5. + T cells: changing strategies for cancer treatment. Blood 114(3), 589-595 (2009).
6. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 8(2), 89-91 (2005). (Pubitemid 41132735)
7. Garcia-Barros M, Paris F, Cordon-Cardo C et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622), 1155-1159 (2003). (Pubitemid 36583102)
8. Linda A, Trovo M, Bradley JD. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur. J. Radiol. DOI: 10.1016/j. ejrad.2009.10.029 (2009) (Epub ahead of print).
9. Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT).Lung Cancer 69(1), 77-85 (2010).
10. Guckenberger M, Heilman K, Wulf J et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiother. Oncol. 85(3), 435-442 (2007). (Pubitemid 350213147)
11. Takeda T, Takeda A, Kunieda E et al. Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT. AJR Am. J. Roentgenol. 182(5), 1123-1128 (2004). (Pubitemid 38525501)
12. Kato S, Nambu A, Onishi H et al. Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma. Jpn J. Radiol. 28(4), 259-265 (2010).
13. Matsuo Y, Nagata Y, Mizowaki T et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int. J. Clin. Oncol. 12(5), 356-362 (2007). (Pubitemid 47573413)
14. Takeda A, Kunieda E, Takeda T et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 70(4), 1057-1065 (2008). (Pubitemid 351296119)
15. Mac Manus MP, Hicks RJ, Matthews JP et al. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 49(1), 95-108 (2005). (Pubitemid 40798098)
16. Ishimori T, Saga T, Nagata Y et al. 18F-FDG and 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann. Nucl. Med. 18(8), 669-674 (2004). (Pubitemid 40215915)
17. Hoopes DJ, Tann M, Fletcher JW et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56(2), 229-234 (2007). (Pubitemid 46590486)
18. Coon D, Gokhale AS, Burton SA et al. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/ computed tomography-based treatment planning. Clin. Lung Cancer 9(4), 217-221 (2008).
19. Fuss M, Salter BJ, Herman TS, Thomas CR. Metabolic PET imaging for stereotactic body radiation therapy (SBRT) planning and therapy response assessment of pulmonary malignancies. Int. J. Radiat. Oncol. Biol. Phys. 63(Suppl. 1), S412 (2005).
20. Feigenberg S, Yu JQM, Eade TN. FDG PET response by 3 months following stereotactic body radiotherapy for non-small cell lung cancer may be an early surrogate of local failure. Int. J. Radiat. Oncol. Biol. Phys. 69(3 Suppl. 1), S479-S480 (2007).
21. Henderson MA, Hoopes DJ, Fletcher JW et al. A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 76(3), 789-795 (2010).
22. Matsuo Y, Nakamoto Y, Nagata Y et al. Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer. Radiother. Oncol. 97(2), 200-204 (2010).
23. Pan CC, Kavanagh BD, Dawson LA et al. Radiation-associated liver injury. Int. J. Radiat. Oncol. Biol. Phys. 76(3 Suppl.), S94-S100 (2010).
24. Herfarth KK, Hof H, Bahner ML et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int. J. Radiat. Oncol. Biol. Phys. 57(2), 444-451 (2003). (Pubitemid 37040941)
25. Olsen CC, Welsh J, Kavanagh BD et al. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 73(5), 1414-1424 (2009).
26. Price TR, Perkins SM, Sandrasegaran K et al. Evaluation of response after stereotactic body radiation therapy for hepatocellular carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 75(3 Suppl.), S677-S678 (2009).
27. Zook JE, Sandrasegaran K, Saxena R et al. Orthotopic liver transplant (OLT) following stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC): radiologic and pathologic correlation. Int. J. Radiat. Oncol. Biol. Phys. 75(3 Suppl.), S285-S286 (2009).
28. Casamassima F, Masi L, Menichelli C et al. IGRT stereotactic hypofractionated radiotherapy for treatment of focal liver malignancies. Int. J. Radiat. Oncol. Biol. Phys. 72(1 Suppl. 1), S277-S278 (2008).
29. Krix M, Plathow C, Essig M et al. Monitoring of liver metastases after stereotactic radiotherapy using low-MI contrast-enhanced ultrasound - initial results. Eur. Radiol. 15(4), 677-684 (2005).
30. Hof H, Zgoda J, Nill S et al. Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 77(5), 1369-1374 (2010).
31. Rajagopalan MS, Heron DE. Role of PET/CT imaging in stereotactic body radiotherapy. Future Oncol. 6(2), 305-317 (2010).